Business

TGA backs NeuroScientific stem cell assault on Crohn’s disease

Australia’s drug regulator has greenlit NeuroScientific to treat its first patients with Crohn’s disease using the company’s patented stem cell therapy, “StemSmart”.

Business / Companies

Brisbane Times – Business

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Business